However, significant higher methylation frequencies for SPAG6, NKX2-6 and ITIH5 were observed in DCIS samples from the test- compared to the validation cohort (Figure 3A–3D). This evidence concerns the gene ITIH5 and ductal breast carcinoma in situ.